Strides Pharma Science Ltd (STAR)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 875.05
% Change: -0.45% (Prev Close: 879.00)

Volume: 1,77,622
% Change: 62.53% (Prev Volume: 1,09,287)

Delivery: 66,546
Delivery % : 37.46
% Change: 30.55% (Prev Delivery: 50,974)

Turnover: 1,564 Lacs
% Change: 61.28% (Prev Turnover: 970)

💹 EOD Valuation

P/E Ratio: 23.61
P/B Ratio: 3.16
Market Cap: 8068 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: STAR
Market Cap: 7961 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 972.00
52 Week Low: 513.05

All-Time High: 972.00 Rs.
All-Time Low: 26.00 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
9.08% | 14.59% | 44.17% | 40.29% | 79.46%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 28.30%

Change (3Y | 1Y): -2.07% | 0.00%

Pledged %: 50.10%

FII Holding

FII Holding: 28.02%

Change (3Y | 1Y): 6.81% | -0.30%

DII Holding

DII Holding: 13.30%

Change (3Y | 1Y): -3.33% | -0.42%

Public Holding: 30.38%


🏦 Financial Strength

Debt to Equity: 0.74
Debt: 1879.63 Rs. Cr.

Book Value: 276.77 Rs.
Current Ratio: 1.17
Interest Coverage: 3.10
Free Cash Flow: 509.97 Rs. Cr.


📈 Growth & Sales

Sales Growth: 12.86%

Sales Growth Qtr (YOY | QoQ):
6.20% | -5.94%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
10.65% | 14.14% | 12.86%


💰 Profit & Earnings

Profit Growth %

Profit Growth: 205.56%

Profit Growth Qtr (YOY | QoQ):
41.26% | 23.35%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
124.04% | 157.16% | 205.56%


EPS Rs.

EPS (TTM): 37.07 Rs.

EPS Qtr (Last Year | Latest):
364.69 Rs. | 10.80 Rs.

EPS Annual (Last Annual | Annual March):
-7.68 Rs. | 389.75 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
122.76% | 155.18%


Net Profit Rs. Cr.

Net Profit (TTM): 353.52 Rs. Cr.

Net Profit (Annual - March): 3597.52 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
3349.58| 85.61 | 105.60


EBITDA Rs. Cr.

EBITDA (Quarter): 226.76 Rs. Cr.
EBITDA (Previous Yr Ql): 201.16 Rs. Cr.

EBITDA (Annual - March): 856.65 Rs. Cr.
EBITDA (Previous Annual): 565.89 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
13.12% | 337.64%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 17.93%

OPM Qtr (Previous | Current):
18.30% | 19.48%

OPM Annual (5 Yrs | Last Yr | March):
10.16% | 13.58% | 17.59%


Return on Equity %

ROE: 150.67%

ROE (5 Yrs | 3 Yrs | Last Yr):
28.46% | 50.44% | 4.31%


Return on Capital Employed %

ROCE: 14.68%

ROCE (5 Yrs | 3 Yrs | Last Yr):
4.92% | 7.21% | 7.20%


Return on Assets %

ROA (TTM): 60.15%

ROA (5 Yrs | 3 Yrs | Last Yr):
11.81% | 19.74% | 2.02%



PEG Ratio: 0.14
Dividend Yield: 0.46%

PE 3 Yrs: 30.40
PE 5 Yrs: 23.89

Dividend Yield: 0.46%


👥 Company

Strides Pharma Science Ltd

STAR

Promoter Holding: %